ANVISA Brazil - Successful Renewal - Ahmedabad Mehsana - Lambda CRO
ANVISA Accreditation renewed successfully for Lambda’s Ahmedabad and Mehsana Facilities
NEWS
A Bioequivalence Study of Pertuzumab 420 mg Solution for Infusion
Clinical Insights from a Bioequivalence Study of Pertuzumab 420 mg Solution for Infusion
blog
Bioanalytical Methods - Assay List | Lambda-Novum
Bioanalytical Assays – Methods Library
Lambda Therapeutic Research provides QPPV services across the EU and UK, offering companies a reliable framework to meet regulatory expectations and maintain inspection readiness at all times.
Qualified Person for Pharmacovigilance (QPPV): Strengthening Compliance Across the EU and UK
Qualified Person for Pharmacovigilance (QPPV): Strengthening Compliance Across the EU and UK
Lambda Therapeutic Research provides QPPV services across the EU and UK, offering companies a reliable framework to meet regulatory expectations and maintain inspection readiness at all times.
Case-study Phase-I Bioequivalence Study of Trastuzumab SC Injections - Lambda CRO India
Study Insights: Phase-I, Bioequivalence Study of Trastuzumab SC Injection
blog
Bioanalytical Excellence Upheld - Unannounced US FDA inspection concludes with Zero 483s - Lambda CRO
Bioanalytical Excellence Upheld – Unannounced US FDA inspection concludes with Zero 483s
NEWS
Lambda Clears 4 Back-to-Back US FDA PV Inspections in 12 Months Without 483s
Lambda Successfully Completes US FDA Pharmacovigilance Inspection with Zero 483s – 4th Consecutive in One Year
NEWS
Clinical Research Update – June 2025
Clinical Research Updates provides key insights into the latest developments, trends, and breakthroughs shaping the clinical research landscape. Stay informed with concise summaries of regulatory updates, industry collaborations, and advancements…